Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
68 participants
INTERVENTIONAL
2016-08-31
2018-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The goal of this study is to compare a low FODMAP (modified healthy) diet to a high FODMAP (typical healthy) diet for effect on Veterans with IBS and symptoms of Gulf War illness.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of the Low FODMAP Diet and Dietary Oligofructose on Gastrointestinal Form, Function and Microbiota
NCT02259465
Effects of Low FODMAP Diet on Leaky Gut
NCT04526808
Low FODMAPs Diet in Gastrointestinal Disorders
NCT03644602
Implementing a Low FODMAP Diet in Irritable Bowel Syndrome Patients
NCT03948854
Effect of a Low- Fermentable-Oligo-Di- Monosaccharides and Polyols Diet Group Intervention on IBS Symptoms and Fatigue
NCT05124262
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Veterans who were deployed and served in Operation Desert Storm and Desert Shield will be recruited to participate.
The two study diets to be provided to the Veterans and compared are:
Low FODMAP (modified healthy) diet:
High FODMAP (typical healthy) diet:
The FODMAP content of this diet will be higher than low FODMAP diet.
All questionnaires will be answered and measurements performed at baseline, end of treatment and at follow-up visits.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low FODMAP (modified healthy) Diet
Low FODMAP diet for 3 weeks. Veterans will be provided a diet containing foods low in FODMAP.
Low FODMAP Diet
Diet low in foods containing Fermentable Oligo-, Di-, and Mono-saccharides and Polyols
High FODMAP (typical healthy) Diet
High FODMAP diet for 3 weeks. Veterans will be provided a typically healthy diet following US Dietary Guidelines, containing foods high in FODMAPs
High FODMAP Diet
Typical diet of foods containing Fermentable Oligo-, Di-, and Mono-saccharides and Polyols
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low FODMAP Diet
Diet low in foods containing Fermentable Oligo-, Di-, and Mono-saccharides and Polyols
High FODMAP Diet
Typical diet of foods containing Fermentable Oligo-, Di-, and Mono-saccharides and Polyols
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Men and women age 25-90 years
* Gulf War Illness: Veterans will have Rome III criteria for IBS and two or more of the non-intestinal symptom groups (chronic-once a week or more often-fatigue, insomnia, joint pains, general stiffness, and headache, neurological an mood, respirator and skin symptoms)
* Symptoms of \> 6 months duration
* No significant findings on physical examination, complete blood count and clinical chemistry panel
Exclusion Criteria
* Current evidence of any lower gastrointestinal disorder such as celiac disease or inflammatory bowel disease
* Clinically significant chronic disease: HIV, cardiac, pulmonary, hepatic or renal dysfunction
* Presence of Giardia antigen, and Clostridium difficile toxin in stool
* Current history of drug or alcohol abuse
* Investigator perception of patient's inability to comply with study protocol
* Recent change in gastrointestinal medications
* Subject is currently participating in another research protocol. These subjects will be allowed to enroll after a washout period of one month.
25 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United States Department of Defense
FED
Ashok Tuteja
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ashok Tuteja
Professor Gastroenterology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ashok K Tuteja, M.D.
Role: PRINCIPAL_INVESTIGATOR
George E. Wahlen VA Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
George E Wahlen VA Medical Center
Salt Lake City, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB_00087668
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.